CDC Vaccine Panel Announce Critical Shift in Hepatitis B Vaccine Guidelines 05/12/2025 Sophia Samantaroy A United States vaccine advisory panel, recently reformed to include known vaccine skeptics, voted to eliminate a three-decade-long recommendation that all newborns in the US receive a vaccine to protect against hepatitis B (Hep B) at birth – a change that was denounced immediately by medical groups like the American Academy of Pediatrics and the […] Continue reading -> Collaboration Across Africa is Key to Increasing Clinical Trials 05/12/2025 Sophia Samantaroy In Kenya, toxicologists and epidemiologists face a difficult choice: to pursue better-paid work to support their families, or volunteer as reviewers for vaccine clinical trials, often without the compensation needed to cover even their children’s school fees. Their dilemma underscores a broader challenge in Africa’s clinical research ecosystem. Slow, duplicative approval processes and limited regulatory […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> WHO Issues First-Ever Guidelines for GLP-1 Drugs – Including Obesity 04/12/2025 Sophia Samantaroy First-ever WHO guidelines recommending the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults has been issued by the World Health Organization – in what the global health agency said is a “conditional” sign of approval for the cutting edge medications that have become widely popular. The new WHO recommendations go […] Continue reading -> European Commission Moves to Ease AI Rules as WHO Warns of Patient Risks due to Regulatory Vacuum 19/11/2025 Felix Sassmannshausen Technological advances in Artificial Intelligence applications for healthcare are quickly outpacing regulatory and ethical safeguards, creating a dangerous gap in patient safety, warns a milestone report on AI in Health Systems, published Wednesday by the World Health Organization’s European Region (WHO/EURO). Paradoxically, the WHO’s urgent call for tighter AI regulation coincided with a far-reaching European […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> From Texas to the G20: The Man Leading the World’s Brain Health Movement 31/10/2025 Maayan Hoffman As the G-20 Health Ministers meeting takes place next week in Johannesburg, South Africa, a new global coalition is trying to put Alzheimer’s and dementia-related diseases on the priority list of the world’s major economies; and there’s one man who stands out as a driving force behind this movement. In his video “Leadership Lessons from […] Continue reading -> Top African Pharma Executive Bluntly Lists Barriers to Local Manufacturing 23/10/2025 Matthew Hattingh DURBAN, South Africa — A top executive at Africa’s biggest drug company shared a few home truths with the continent’s health policymakers about the obstacles to local manufacturing at the Conference on Public Health in Africa (CPHIA) 2025. Aspen Pharmacare’s Dr Stavros Nicolaou blamed regulatory bottlenecks and procurement policies for the failure of drug manufacturers […] Continue reading -> Drive to Include Pregnant and Breastfeeding Women and Children in Clinical Trials 17/10/2025 Kerry Cullinan The first pregnant woman with malaria was enrolled in a clinical trial in Mali to compare three different malaria treatment regimens earlier this month – a historic event as pregnant and breastfeeding women and babies are seldom included in clinical trials despite being more vulnerable to several illnesses. But there is growing momentum for including […] Continue reading -> Toxic Cough Syrup, Weak Oversight: India’s Unending Drug Safety Crisis 15/10/2025 Arsalan Bukhari At least 22 children have died in India this month after consuming a contaminated cough syrup found to contain nearly 45% diethylene glycol (DEG), a toxic industrial solvent used in brake fluid and antifreeze. The concentration is hundreds of times above the permissible limit of 0.1% set by pharmacopeial safety standards. The syrup, branded Coldrif, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Collaboration Across Africa is Key to Increasing Clinical Trials 05/12/2025 Sophia Samantaroy In Kenya, toxicologists and epidemiologists face a difficult choice: to pursue better-paid work to support their families, or volunteer as reviewers for vaccine clinical trials, often without the compensation needed to cover even their children’s school fees. Their dilemma underscores a broader challenge in Africa’s clinical research ecosystem. Slow, duplicative approval processes and limited regulatory […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> WHO Issues First-Ever Guidelines for GLP-1 Drugs – Including Obesity 04/12/2025 Sophia Samantaroy First-ever WHO guidelines recommending the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults has been issued by the World Health Organization – in what the global health agency said is a “conditional” sign of approval for the cutting edge medications that have become widely popular. The new WHO recommendations go […] Continue reading -> European Commission Moves to Ease AI Rules as WHO Warns of Patient Risks due to Regulatory Vacuum 19/11/2025 Felix Sassmannshausen Technological advances in Artificial Intelligence applications for healthcare are quickly outpacing regulatory and ethical safeguards, creating a dangerous gap in patient safety, warns a milestone report on AI in Health Systems, published Wednesday by the World Health Organization’s European Region (WHO/EURO). Paradoxically, the WHO’s urgent call for tighter AI regulation coincided with a far-reaching European […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> From Texas to the G20: The Man Leading the World’s Brain Health Movement 31/10/2025 Maayan Hoffman As the G-20 Health Ministers meeting takes place next week in Johannesburg, South Africa, a new global coalition is trying to put Alzheimer’s and dementia-related diseases on the priority list of the world’s major economies; and there’s one man who stands out as a driving force behind this movement. In his video “Leadership Lessons from […] Continue reading -> Top African Pharma Executive Bluntly Lists Barriers to Local Manufacturing 23/10/2025 Matthew Hattingh DURBAN, South Africa — A top executive at Africa’s biggest drug company shared a few home truths with the continent’s health policymakers about the obstacles to local manufacturing at the Conference on Public Health in Africa (CPHIA) 2025. Aspen Pharmacare’s Dr Stavros Nicolaou blamed regulatory bottlenecks and procurement policies for the failure of drug manufacturers […] Continue reading -> Drive to Include Pregnant and Breastfeeding Women and Children in Clinical Trials 17/10/2025 Kerry Cullinan The first pregnant woman with malaria was enrolled in a clinical trial in Mali to compare three different malaria treatment regimens earlier this month – a historic event as pregnant and breastfeeding women and babies are seldom included in clinical trials despite being more vulnerable to several illnesses. But there is growing momentum for including […] Continue reading -> Toxic Cough Syrup, Weak Oversight: India’s Unending Drug Safety Crisis 15/10/2025 Arsalan Bukhari At least 22 children have died in India this month after consuming a contaminated cough syrup found to contain nearly 45% diethylene glycol (DEG), a toxic industrial solvent used in brake fluid and antifreeze. The concentration is hundreds of times above the permissible limit of 0.1% set by pharmacopeial safety standards. The syrup, branded Coldrif, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> WHO Issues First-Ever Guidelines for GLP-1 Drugs – Including Obesity 04/12/2025 Sophia Samantaroy First-ever WHO guidelines recommending the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults has been issued by the World Health Organization – in what the global health agency said is a “conditional” sign of approval for the cutting edge medications that have become widely popular. The new WHO recommendations go […] Continue reading -> European Commission Moves to Ease AI Rules as WHO Warns of Patient Risks due to Regulatory Vacuum 19/11/2025 Felix Sassmannshausen Technological advances in Artificial Intelligence applications for healthcare are quickly outpacing regulatory and ethical safeguards, creating a dangerous gap in patient safety, warns a milestone report on AI in Health Systems, published Wednesday by the World Health Organization’s European Region (WHO/EURO). Paradoxically, the WHO’s urgent call for tighter AI regulation coincided with a far-reaching European […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> From Texas to the G20: The Man Leading the World’s Brain Health Movement 31/10/2025 Maayan Hoffman As the G-20 Health Ministers meeting takes place next week in Johannesburg, South Africa, a new global coalition is trying to put Alzheimer’s and dementia-related diseases on the priority list of the world’s major economies; and there’s one man who stands out as a driving force behind this movement. In his video “Leadership Lessons from […] Continue reading -> Top African Pharma Executive Bluntly Lists Barriers to Local Manufacturing 23/10/2025 Matthew Hattingh DURBAN, South Africa — A top executive at Africa’s biggest drug company shared a few home truths with the continent’s health policymakers about the obstacles to local manufacturing at the Conference on Public Health in Africa (CPHIA) 2025. Aspen Pharmacare’s Dr Stavros Nicolaou blamed regulatory bottlenecks and procurement policies for the failure of drug manufacturers […] Continue reading -> Drive to Include Pregnant and Breastfeeding Women and Children in Clinical Trials 17/10/2025 Kerry Cullinan The first pregnant woman with malaria was enrolled in a clinical trial in Mali to compare three different malaria treatment regimens earlier this month – a historic event as pregnant and breastfeeding women and babies are seldom included in clinical trials despite being more vulnerable to several illnesses. But there is growing momentum for including […] Continue reading -> Toxic Cough Syrup, Weak Oversight: India’s Unending Drug Safety Crisis 15/10/2025 Arsalan Bukhari At least 22 children have died in India this month after consuming a contaminated cough syrup found to contain nearly 45% diethylene glycol (DEG), a toxic industrial solvent used in brake fluid and antifreeze. The concentration is hundreds of times above the permissible limit of 0.1% set by pharmacopeial safety standards. The syrup, branded Coldrif, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Issues First-Ever Guidelines for GLP-1 Drugs – Including Obesity 04/12/2025 Sophia Samantaroy First-ever WHO guidelines recommending the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults has been issued by the World Health Organization – in what the global health agency said is a “conditional” sign of approval for the cutting edge medications that have become widely popular. The new WHO recommendations go […] Continue reading -> European Commission Moves to Ease AI Rules as WHO Warns of Patient Risks due to Regulatory Vacuum 19/11/2025 Felix Sassmannshausen Technological advances in Artificial Intelligence applications for healthcare are quickly outpacing regulatory and ethical safeguards, creating a dangerous gap in patient safety, warns a milestone report on AI in Health Systems, published Wednesday by the World Health Organization’s European Region (WHO/EURO). Paradoxically, the WHO’s urgent call for tighter AI regulation coincided with a far-reaching European […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> From Texas to the G20: The Man Leading the World’s Brain Health Movement 31/10/2025 Maayan Hoffman As the G-20 Health Ministers meeting takes place next week in Johannesburg, South Africa, a new global coalition is trying to put Alzheimer’s and dementia-related diseases on the priority list of the world’s major economies; and there’s one man who stands out as a driving force behind this movement. In his video “Leadership Lessons from […] Continue reading -> Top African Pharma Executive Bluntly Lists Barriers to Local Manufacturing 23/10/2025 Matthew Hattingh DURBAN, South Africa — A top executive at Africa’s biggest drug company shared a few home truths with the continent’s health policymakers about the obstacles to local manufacturing at the Conference on Public Health in Africa (CPHIA) 2025. Aspen Pharmacare’s Dr Stavros Nicolaou blamed regulatory bottlenecks and procurement policies for the failure of drug manufacturers […] Continue reading -> Drive to Include Pregnant and Breastfeeding Women and Children in Clinical Trials 17/10/2025 Kerry Cullinan The first pregnant woman with malaria was enrolled in a clinical trial in Mali to compare three different malaria treatment regimens earlier this month – a historic event as pregnant and breastfeeding women and babies are seldom included in clinical trials despite being more vulnerable to several illnesses. But there is growing momentum for including […] Continue reading -> Toxic Cough Syrup, Weak Oversight: India’s Unending Drug Safety Crisis 15/10/2025 Arsalan Bukhari At least 22 children have died in India this month after consuming a contaminated cough syrup found to contain nearly 45% diethylene glycol (DEG), a toxic industrial solvent used in brake fluid and antifreeze. The concentration is hundreds of times above the permissible limit of 0.1% set by pharmacopeial safety standards. The syrup, branded Coldrif, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Commission Moves to Ease AI Rules as WHO Warns of Patient Risks due to Regulatory Vacuum 19/11/2025 Felix Sassmannshausen Technological advances in Artificial Intelligence applications for healthcare are quickly outpacing regulatory and ethical safeguards, creating a dangerous gap in patient safety, warns a milestone report on AI in Health Systems, published Wednesday by the World Health Organization’s European Region (WHO/EURO). Paradoxically, the WHO’s urgent call for tighter AI regulation coincided with a far-reaching European […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> From Texas to the G20: The Man Leading the World’s Brain Health Movement 31/10/2025 Maayan Hoffman As the G-20 Health Ministers meeting takes place next week in Johannesburg, South Africa, a new global coalition is trying to put Alzheimer’s and dementia-related diseases on the priority list of the world’s major economies; and there’s one man who stands out as a driving force behind this movement. In his video “Leadership Lessons from […] Continue reading -> Top African Pharma Executive Bluntly Lists Barriers to Local Manufacturing 23/10/2025 Matthew Hattingh DURBAN, South Africa — A top executive at Africa’s biggest drug company shared a few home truths with the continent’s health policymakers about the obstacles to local manufacturing at the Conference on Public Health in Africa (CPHIA) 2025. Aspen Pharmacare’s Dr Stavros Nicolaou blamed regulatory bottlenecks and procurement policies for the failure of drug manufacturers […] Continue reading -> Drive to Include Pregnant and Breastfeeding Women and Children in Clinical Trials 17/10/2025 Kerry Cullinan The first pregnant woman with malaria was enrolled in a clinical trial in Mali to compare three different malaria treatment regimens earlier this month – a historic event as pregnant and breastfeeding women and babies are seldom included in clinical trials despite being more vulnerable to several illnesses. But there is growing momentum for including […] Continue reading -> Toxic Cough Syrup, Weak Oversight: India’s Unending Drug Safety Crisis 15/10/2025 Arsalan Bukhari At least 22 children have died in India this month after consuming a contaminated cough syrup found to contain nearly 45% diethylene glycol (DEG), a toxic industrial solvent used in brake fluid and antifreeze. The concentration is hundreds of times above the permissible limit of 0.1% set by pharmacopeial safety standards. The syrup, branded Coldrif, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> From Texas to the G20: The Man Leading the World’s Brain Health Movement 31/10/2025 Maayan Hoffman As the G-20 Health Ministers meeting takes place next week in Johannesburg, South Africa, a new global coalition is trying to put Alzheimer’s and dementia-related diseases on the priority list of the world’s major economies; and there’s one man who stands out as a driving force behind this movement. In his video “Leadership Lessons from […] Continue reading -> Top African Pharma Executive Bluntly Lists Barriers to Local Manufacturing 23/10/2025 Matthew Hattingh DURBAN, South Africa — A top executive at Africa’s biggest drug company shared a few home truths with the continent’s health policymakers about the obstacles to local manufacturing at the Conference on Public Health in Africa (CPHIA) 2025. Aspen Pharmacare’s Dr Stavros Nicolaou blamed regulatory bottlenecks and procurement policies for the failure of drug manufacturers […] Continue reading -> Drive to Include Pregnant and Breastfeeding Women and Children in Clinical Trials 17/10/2025 Kerry Cullinan The first pregnant woman with malaria was enrolled in a clinical trial in Mali to compare three different malaria treatment regimens earlier this month – a historic event as pregnant and breastfeeding women and babies are seldom included in clinical trials despite being more vulnerable to several illnesses. But there is growing momentum for including […] Continue reading -> Toxic Cough Syrup, Weak Oversight: India’s Unending Drug Safety Crisis 15/10/2025 Arsalan Bukhari At least 22 children have died in India this month after consuming a contaminated cough syrup found to contain nearly 45% diethylene glycol (DEG), a toxic industrial solvent used in brake fluid and antifreeze. The concentration is hundreds of times above the permissible limit of 0.1% set by pharmacopeial safety standards. The syrup, branded Coldrif, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
From Texas to the G20: The Man Leading the World’s Brain Health Movement 31/10/2025 Maayan Hoffman As the G-20 Health Ministers meeting takes place next week in Johannesburg, South Africa, a new global coalition is trying to put Alzheimer’s and dementia-related diseases on the priority list of the world’s major economies; and there’s one man who stands out as a driving force behind this movement. In his video “Leadership Lessons from […] Continue reading -> Top African Pharma Executive Bluntly Lists Barriers to Local Manufacturing 23/10/2025 Matthew Hattingh DURBAN, South Africa — A top executive at Africa’s biggest drug company shared a few home truths with the continent’s health policymakers about the obstacles to local manufacturing at the Conference on Public Health in Africa (CPHIA) 2025. Aspen Pharmacare’s Dr Stavros Nicolaou blamed regulatory bottlenecks and procurement policies for the failure of drug manufacturers […] Continue reading -> Drive to Include Pregnant and Breastfeeding Women and Children in Clinical Trials 17/10/2025 Kerry Cullinan The first pregnant woman with malaria was enrolled in a clinical trial in Mali to compare three different malaria treatment regimens earlier this month – a historic event as pregnant and breastfeeding women and babies are seldom included in clinical trials despite being more vulnerable to several illnesses. But there is growing momentum for including […] Continue reading -> Toxic Cough Syrup, Weak Oversight: India’s Unending Drug Safety Crisis 15/10/2025 Arsalan Bukhari At least 22 children have died in India this month after consuming a contaminated cough syrup found to contain nearly 45% diethylene glycol (DEG), a toxic industrial solvent used in brake fluid and antifreeze. The concentration is hundreds of times above the permissible limit of 0.1% set by pharmacopeial safety standards. The syrup, branded Coldrif, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Top African Pharma Executive Bluntly Lists Barriers to Local Manufacturing 23/10/2025 Matthew Hattingh DURBAN, South Africa — A top executive at Africa’s biggest drug company shared a few home truths with the continent’s health policymakers about the obstacles to local manufacturing at the Conference on Public Health in Africa (CPHIA) 2025. Aspen Pharmacare’s Dr Stavros Nicolaou blamed regulatory bottlenecks and procurement policies for the failure of drug manufacturers […] Continue reading -> Drive to Include Pregnant and Breastfeeding Women and Children in Clinical Trials 17/10/2025 Kerry Cullinan The first pregnant woman with malaria was enrolled in a clinical trial in Mali to compare three different malaria treatment regimens earlier this month – a historic event as pregnant and breastfeeding women and babies are seldom included in clinical trials despite being more vulnerable to several illnesses. But there is growing momentum for including […] Continue reading -> Toxic Cough Syrup, Weak Oversight: India’s Unending Drug Safety Crisis 15/10/2025 Arsalan Bukhari At least 22 children have died in India this month after consuming a contaminated cough syrup found to contain nearly 45% diethylene glycol (DEG), a toxic industrial solvent used in brake fluid and antifreeze. The concentration is hundreds of times above the permissible limit of 0.1% set by pharmacopeial safety standards. The syrup, branded Coldrif, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Drive to Include Pregnant and Breastfeeding Women and Children in Clinical Trials 17/10/2025 Kerry Cullinan The first pregnant woman with malaria was enrolled in a clinical trial in Mali to compare three different malaria treatment regimens earlier this month – a historic event as pregnant and breastfeeding women and babies are seldom included in clinical trials despite being more vulnerable to several illnesses. But there is growing momentum for including […] Continue reading -> Toxic Cough Syrup, Weak Oversight: India’s Unending Drug Safety Crisis 15/10/2025 Arsalan Bukhari At least 22 children have died in India this month after consuming a contaminated cough syrup found to contain nearly 45% diethylene glycol (DEG), a toxic industrial solvent used in brake fluid and antifreeze. The concentration is hundreds of times above the permissible limit of 0.1% set by pharmacopeial safety standards. The syrup, branded Coldrif, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Toxic Cough Syrup, Weak Oversight: India’s Unending Drug Safety Crisis 15/10/2025 Arsalan Bukhari At least 22 children have died in India this month after consuming a contaminated cough syrup found to contain nearly 45% diethylene glycol (DEG), a toxic industrial solvent used in brake fluid and antifreeze. The concentration is hundreds of times above the permissible limit of 0.1% set by pharmacopeial safety standards. The syrup, branded Coldrif, […] Continue reading -> Posts navigation Older posts